Health Care Down as Novartis, Boston Scientific Weigh - Health Care Roundup
Dow Jones
Yesterday
Health-care companies fell after growth warnings from two major medical-device makers and a disappointing clinical trial.
Shares of Novartis plunged after one of the company's leading drug candidates failed to show significant progress on a late-stage trial on sufferers of a neuromuscular condition.
Medical-device maker Boston Scientific said it likely would not meet its financial guidance due to the cyberattack that has disrupted its operations.
Shares of Stryker declined after the maker of orthopedic implants and other medical technology said a lack of supply continues to hamper its peripheral vascular business.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.